149 related articles for article (PubMed ID: 9148008)
1. Prevention of portal hypertension by propranolol and spironolactone in rats with bile duct ligation.
Oberti F; Rifflet H; Maïga MY; Pilette C; Gallois Y; Douay O; Le Jeune JJ; Saumet JL; Calès P
J Hepatol; 1997 Jan; 26(1):167-73. PubMed ID: 9148008
[TBL] [Abstract][Full Text] [Related]
2. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation.
Oberti F; Pilette C; Rifflet H; Maïga MY; Moreau A; Gallois Y; Girault A; le Bouil A; Le Jeune JJ; Saumet JL; Feldmann G; Calès P
J Hepatol; 1997 Jun; 26(6):1363-71. PubMed ID: 9210625
[TBL] [Abstract][Full Text] [Related]
3. Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats.
D'Amico M; Mejías M; García-Pras E; Abraldes JG; García-Pagán JC; Fernández M; Bosch J
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(10):G1191-8. PubMed ID: 22403792
[TBL] [Abstract][Full Text] [Related]
4. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
Fernández M; Pizcueta P; García-Pagán JC; Feu F; Cirera I; Bosch J; Rodés J
Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
[TBL] [Abstract][Full Text] [Related]
5. Combined administration of propranolol + AG490 offers better effects on portal hypertensive rats with cirrhosis.
Wang D; Wang Q; Yin J; Dong R; Wang Q; Du X; Lu J
J Gastroenterol Hepatol; 2016 May; 31(5):1037-44. PubMed ID: 26487394
[TBL] [Abstract][Full Text] [Related]
6. Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.
Heller J; Shiozawa T; Trebicka J; Hennenberg M; Schepke M; Neef M; Sauerbruch T
Eur J Clin Invest; 2003 Nov; 33(11):1006-12. PubMed ID: 14636305
[TBL] [Abstract][Full Text] [Related]
7. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic effects of combined treatment with molsidomine and propranolol on portal hypertension in conscious and unrestrained cirrhotic rats.
Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
J Gastroenterol Hepatol; 1996 Oct; 11(10):985-92. PubMed ID: 8912139
[TBL] [Abstract][Full Text] [Related]
9. Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.
Reboredo M; Chang HC; Barbero R; Rodríguez-Ortigosa CM; Pérez-Vizcaíno F; Morán A; García M; Banales JM; Carreño N; Alegre F; Herrero I; Quiroga J; Prieto J; Sangro B
PLoS One; 2013; 8(1):e52683. PubMed ID: 23341903
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic effects of chronic tetrandrine and propranolol administration on portal hypertensive rats.
Huang YT; Liu TB; Lin HC; Yang MC; Hong CY
Pharmacology; 1997 May; 54(5):225-31. PubMed ID: 9380768
[TBL] [Abstract][Full Text] [Related]
11. Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation.
Poo JL; Feldmann G; Moreau A; Gaudin C; Lebrec D
J Hepatol; 1993 Aug; 19(1):90-4. PubMed ID: 8301049
[TBL] [Abstract][Full Text] [Related]
12. Systemic and splanchnic hemodynamics following hemorrhage and volume restitution with Haemaccel in portal hypertensive rats: the effect of propranolol.
Hilzenrat N; Arish A; Yaari A; Sikuler E
J Gastroenterol Hepatol; 2001 Jul; 16(7):796-800. PubMed ID: 11446889
[TBL] [Abstract][Full Text] [Related]
13. Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed rats.
Lin HC; Soubrane O; Cailmail S; Lebrec D
J Hepatol; 1991 Sep; 13(2):213-9. PubMed ID: 1744426
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment of portal hypertension with ritanserin and propranolol in conscious and unrestrained cirrhotic rats.
Pomier-Layrargues G; Giroux L; Rocheleau B; Huet PM
Hepatology; 1992 May; 15(5):878-82. PubMed ID: 1568730
[TBL] [Abstract][Full Text] [Related]
15. Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model.
Bosch J; Enriquez R; Groszmann RJ; Storer EH
Hepatology; 1983; 3(6):1002-7. PubMed ID: 6629314
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of a clonidine-induced decrease in portal pressure in normal and cirrhotic conscious rats.
Roulot D; Braillon A; Gaudin C; Ozier Y; Girod C; Lebrec D
Hepatology; 1989 Oct; 10(4):477-81. PubMed ID: 2777209
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of eight-day octreotide and propranolol administration in portal hypertensive rats.
Huang YT; Cheng YR; Lin HC; Hou MC; Lee SD; Hong CY
Dig Dis Sci; 1998 Feb; 43(2):358-64. PubMed ID: 9512131
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats.
Schwabl P; Payer BA; Grahovac J; Klein S; Horvatits T; Mitterhauser M; Stift J; Boucher Y; Trebicka J; Trauner M; Angermayr B; Fuhrmann V; Reiberger T; Peck-Radosavljevic M
J Hepatol; 2014 Jun; 60(6):1135-42. PubMed ID: 24530596
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis and/or portal hypertension.
Croquet V; Moal F; Veal N; Wang J; Oberti F; Roux J; Vuillemin E; Gallois Y; Douay O; Chappard D; Calès P
J Hepatol; 2002 Dec; 37(6):773-80. PubMed ID: 12445418
[TBL] [Abstract][Full Text] [Related]
20. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.
Pizcueta MP; de Lacy AM; Kravetz D; Bosch J; Rodés J
Hepatology; 1989 Dec; 10(6):953-7. PubMed ID: 2583690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
